Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,252 GBX | +0.02% | +3.68% | +6.40% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.40% | 215B | |
+25.46% | 659B | |
+25.73% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+7.85% | 210B | |
-5.93% | 200B | |
-8.79% | 149B | |
-5.59% | 146B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Imfinzi Plus Chemotherapy Receives FDA Priority Review for Biliary Tract Cancer Patients